The rheumatic diseases especially rheumatoid arthritis have been causing immense suffering to the people throughout the world. This state of affairs has been mainly due to lack of proper understanding of the disease process. Intensive studies have put-forth several concepts of its etiopathogenesis. Out of these the definite role of genetics and immunity has been established (Kishore 1965) .
The exact mechanism and the beginning of the process is not still understood. As such, efforts are being continued to study the etiopathogenesis of the disease. In this context the ancient Indian concept of role of impaired gastrointestinal function (enteropathy) has also been taken up for investigation more than two decades ago (Kishore 1965) . It is interesting to note that the modern scientific workers in other parts of the world have also putforth certain similar theories of its causation (Shat in 1964). An attempt has been made in this paper to evaluate the theory of ancient Indian medicine -Ayurveda, in relation to the modern medical concept. These may be broadly grouped into three. The first dealing with the evolution of the disease, its etiopathogenesis, the second diseases, the pathological, Biochemical as well as therapeutic data published in support of this concept and finally the details of trials of Sunthi in series of 4 trials consisting of 265 patients.
Evolution:
The antiquity of this disease may be traced from the very beginning of the civilization on the basis of findings on ancient Egyptian mummies.
Though its description in medical sciences was initiated by Hippocrates (6 th century B. C.) the first clinical description of this disease was only put forth by Arteus (100 A D). The term "Rheumatis" was coined by Galen (199 A.D.) who also specified the "Arthritis" to indicate joint disease. Further developments in understanding this disease could take place only after more than 1400 years, in the 17 th century further developments in understanding this could take place with the identification of Gout from Rheumatism by de Baileu which was followed by further classification of Rheumatis into acute and chronic varieties (Sydenham 1629 -89 A. D.) the proper clinical description and present nomenclature was put forth only in the middle of last century. Certain concepts of etiology indicating its neurogenic and infective origin were also proposed during this century. The intensive studies on sedimentation rate, hypersensivity/auto immunity and demonstration of "Rheumatoid factor" and its practice / such as the introduction of therapeutic criteria and functional tests in the evaluation of the effect of the treatment, practice of gold salt cortisone and ACTH therapy are some of the important achievements during the first half of this century. Later, detailed studies on the diagnostic significance of rheumatoid factor contributed to development of more serological tests. Since the problem of suitable diagnosis has still remained unsolved, the ARA developed certain criteria, on the basis of serological, radiological, biochemical, pathological and clinical findings on this disease . Certain  new  therapeutic  agents  such  as,  Phenylbutozone, anti-malarials and indomethalicin were also introduced simultaneously. The term intestinal arthritis was introduced subsequently along with the role of enteropathy in the etiopathogenesis and management of this disease.
On the other hand, the description of this disease in Ayurveda dates back about 1000 B.C. In the earlier period the joint diseases were discussed mainly under the title 'Vatarakta'.
The etiological factor i.e. 'Ama' was said to produce various diseases in combination of various Dosas and Dusyas of the body. The same trend continued up to 6 th century A. D. where in the description of manifestations of Ama was given and the diseases occurring due to Ama were termed as Sama. 
Etiopathogenesis
The modern medical sciences have gradually recognized the Rheumatoid arthritis as a systemic disease. Various theories regarding its etiopathogenesis such as neurogenic, vascular, infective, metabolic, endocrinal,auto-immune and psychogenic have peen put forth from time to time. The familial proneness to this disease has clinched the important role of genetics in the etiopathogenesis of this disease. Presently it is being considered as an auto immune disorder though endocrine, metabolic and infection factors are not completely ruled out. In addition, a new proposition assigning crucial role of enteropathy has also been put forth. The pathogenesis of this disease according to this concept revolves round the inherent susceptibility to enteropathy which can be activated by diet (gluten), trauma, infection and drugs acting on small intestine. This enteropathy leads to the malaabsorption and impeded biosynthesis of protein resulting in excessive dissolution of collagen tissues. This process causes further damage to the intestine (Fig. I ).
With the perusal of Ayurvedic literature it is evident that there is ample emphasis, on the gastro -intestinal disturbances as the primary cause of rheumatoid arthritis (Amavata). Hypo functioning of digestive mechanism as a whole is the sheet anchor which leads to incomplete processing of food.
An interesting theory has been advanced that some component of this incompletely proceed food -Ama is absorbed in the system and is capable to produce vascular and tissue changes (Srotobhishyanda). The involvement of Shleshaka Kapha in the pathogenesis of Amavata has got great resemblance with that of connective tissue disorder.
The observation of Yoga Ratnakara in this reference about Grahani Dosa is also very pertinent. The concept of Grahani Dosa is analogous to enteropathy, usually it initiates Grahani Roga (colic disease) but its relation with Amavata (Rheumatoid Arthritis) is another aspect of its clinical manifestation (Fig. 2 ).
Thus the thought in the Indigenous system of medicine in connection with the causation of rheumatoid arthritis, is very much similar with the school of today considering gastrointestinal disorders to be primary; however, a few novelties are also there. Shatin has explained the initiation of vascular and tissue changes in the target organs to be a passive phenomenon following hypoproteinemia as the result of malasbsorption.
On the other hand Ayurveda believes it to be an active phenomenon.
Ama -component of incompletely processed food reacts and interacts with the humours and cells of the body and finally initiates the vascular and tissue changes in the target organs.
According to them various psychological, dietary and other factors only operate through the gastro-intestinal system leading to hypo functioning of digestive mechanism. The role of Ama has a great resemblance with the theory of altered immune mechanism (Tripathy, Shukla and Kishore, 1965) . Allergic manifestations with the absorption of denatured proteins from the intestinal tract is a known example of such a possibility. The exacerbation in the gastrointestinal symptoms during active phase of the disease may also be explained with this hypothesis.
In short according to Ayurveda the various etiological factors operate through the gastro-intestinal axis, leading to its hypo functioning and further damages. Further the incompletely processed food Ama -(having antigenic property) produces the disease following multiple changes in the body. Thus the concepts of gastrointestinal disorder specially enteropathy and altered immune mechanisms are interwoven together in this theory. No doubt hypoproteinemia, the result of enteropathy produces susceptibility to fibrinoid change, which may be precipitated by the action of Ama (Fig. 3) .
Observation on Gastro -Intestinal Disfunction / Impairment
Gastro -intestinal disfunction has been considered to be the cause of all diseases in Ayurveda. Its role in various disease is explicitly discussed. As already mentioned this concept has been very much emphasized in the etiopathogenesis of Amavatarheumatoid arthritis. The observation of clinical manifestations indicating gastrointestinal disfunction such as anorexia, loss of appetite, constipation or diarrhoea have also been discussed in the text books of modern medicine. (Traut 1952 , Duthie 1964 ). In addition certain conditions like non specific ulcerative colitis and regional enteritis have also been reported to be associated with the causation, exacerbation and remission of rheumatoid arthritis. Certain studies have also indicated comparatively higher incidences of gastrointestinal diseases in the patients of rheumatoid arthritis than the diseases of other system (Gibberd 1965 ).
The biochemical and histopathological observations on stomach, liver and small intestine have also been reported from various countries, (Table -I ) also definitely indicated impairment of function of these organs. 80% of cases, alkaline phosphatase raised in more than 50% of cases.
TABLE -I Showing observation on impaired gastro -intestinal function

Parenchymal liver damage.
Intestinal absorption -d -xylose below normal in more than 40% cases, radioiodinated human serum albumin absorption test indicates subnormal value in 2/3 rd of patients.
d -xylose absorption below normal.
d -xylose below normal in all cases (10).
Thyroid function lowered, shortening broadening and infiltration of the villi of the Jejunum.
Clinical trial of sunthi preparation
In order to study the effect of gastrointestinal stimulant drugs in the treatment of rheumatoid arthritis the present series of trials of Sunthi preparations have been taken up. The drug Sunthi -Zingiber officinal (dry) has been selected for trial since this has been extensively recommended as a single drug in simple combinations as well as in most of the compound formulations recommended in Ayurveda for the treatment of this disease. The pharmacodynamic properties of Sunthi are opposite to the properties of Rasa, Kapha and Ama, which are bodily factors (Dosa -Dushyas involved in the etiopathogenesis of this disease. This drug has also shown therapeutic efficacy in the patients of Grahaniroga (enteropathy, M. A. S.) (Dixit et al 1977) which has been said to be the basic pathology in the patients of Amavaa as well.
The combinations for the trial, SunthiGuduchi, Sunthi -Guggulu and Rasonadi Kvatha (Rasona -Sunthi -Nirgundi) have been selected on the basis of their classical description as well as published data supporting their efficacy in the treatment of this disease. In order to have the idea of its comparative efficacy a standard set of Ayurvedic preparation consisting of Yogaraj Guggulu, Vatagajankusha Rasa / Amavatrai Rasa, Maharasnadi Kvatha has also been prescribed to control group of cases.
Materials and Methods
The patients for trials were selected on the basis of ARA criteria (1959) and only clinical findings as morning stiffness, pain in motion, swelling of one joint, swelling of another joint, symmetrical involvement of joints sub-cutaneous nodules over bony prominences along with radiological reports were taken into account. After admission the patients were subjected to detailed clinical examinations pertaining availability of relevant findings, their intensity as well as certain functional tests and measurement of joints. Aspecific proforma evolved was filled up for each patient. In some cases photographs of the affected joints were also taken.
The following treatments in four separate trials were given groupwise as follows (Table 2 ).
In addition to the above medicines, Baluka Sveda and Lepa were given in the acute stage of the disease.
Assessment and Classification of Results.
The assessment of the results has been done according to the changes in clinical findings. In addition, the changes in ESR test, functional tests and measurement of the joints have been noted. The results of the treatment have been classified as follows:
Complete relief: Completely free from signs / symptoms of joints inflammation with free movement of the joints except those due to irreversible changes.
Partial relief: Reduction of signs / symptoms of the joint inflammation and improvement of joint movement to a major extent, but not fully.
No relief:
No response at all or only marginal improvement of the condition.
Drop out:
The patients who discontinued the treatment before stipulated period. 
Observations
The observations on 265 patients in four separate trials have been taken up for a period of more than six years to assess the role of Sunthi and certain other drugs in the treatment of rheumatoid arthritis. The observations on the general clinical profile of patients have been discussed first and the effect of each combination of Sunthi in different trials have been discussed separately.
The general clinical profile
The observations indicated that the disease affects the individuals of either sex in all age groups, though the incidence appears to be maximum in the age group of 21 -30 years (Table -III) , (Figure -4) .
The patients have been suffering with the disease mostly from less than one year duration, though many chronic patients suffering for the duration of more than 10 years were also observed. The knee joints, ankle joints and wrist joints were most commonly affected (Figure -5 ). Certain patients, where X-ray of joints were taken, showed varying degree of changes ranging from Osteoporosis to Anklyosis and fusion of bones. The overall classification of cases taken up for trial as per the ARA criteria has been observed as either "Definite or Classical".
The joint involvement are invariably poly -articular and symmetrical. The ESR has been found to be raised in most of the patients. Though most of the patients were having Gastro -intestinal symptoms such as constipation, loss of appetite etc. certain patients with chronic diarrhoea were also observed. It was also noted that the intensity of the disease was directly related to the intensity of the diarrhoea. Therapeutic efficacy:
The trial of a 12 weeks course of SunthiGuduci in the form of decoction in the dose of 25 -50 ml. three times a day, in comparison to a combination of Yogaraja Guggulu, Vaagajankusa Rasa and Maharasnadi Kvatha has been taken up in 77 patients in two groups. The treatment gradually showed improvement in the pain, swelling and restriction of movement, the cardinal manifestation of the disease in both the groups of treatment. The effect of Sunthi -Guduchi has been relatively better since the percentage of patients with no relief and drop out has been much less than the other set of the treatment and many more patients have been reported partial Relief (Table -4 The ESR have also shown significant reduction in the patients treated with Sunthi -Guduci and in most of the cases it has come within normal limits after treatment.
(
ii) SUNTHI -GUGGULU (A)
A clinical trial of Sunthi -Guggulu in comparision to Yogaraja Guggulu, Amavatari Rasa and Maharasandi Kvatha has been taken up on 63 patients in two groups. 36 patients were treated with a six week course of Sunthi -Guggulu in the dose of 2 gms. Three times a day whereas the 2 nd group of 27 patients were treated with the other combination mentioned above. Remarakable improvement was observed within a short period of treatment with Sunthi -Guggulu and the percentage of patients who reported complete relief and partial relief have been much more with the treatment by Sunthi -Guggulu than the other combination mentioned above (Table  -5 Keeping in view the better efficacy of Sunthi -Guggulu combination, efforts have been made to further assess its effect in a larger series of patients. As such the trial of a six week course of Sunthi -Guggulu alongwith local external treatments have been taken up on 75 patients. The effect of the drugs have been quite significant and it has been observed that almost all the cases who have completed the course have shown definite improvement though, complete relief was observed in a small proportion of cases. Partial relief i.e. more than 50% were observed in 42 cases (Figure -8) . It was an important observation that the patients in the early stage of diseases in younger age groups and the males showed better result of the treatment (Table -6 ). Table -7) , (Figure -9 ). Sharma et al 1981) . Similar view on gastrointestinal disfunction -entropathy has also been assigned etiological role by some modern scientific workers in recent past.
In view of the Ayurvedic concept of Gastro -intestinal etiology of this disease an attempt has been made to assess the effect of Sunthi in the treatment of this disease. This drug has been said to regulate the bowel movement by way of controlling loose and watery motion as well as relieving constipation. The digestive / stimulant action of the drug has been well established. Thus, this drug will be able to alleviate the 'Ama' the chief causative agent of the disease according to Ayurveda. This concept has been put to test on a series of four trials with the various combinations of Sunthi as a major ingredient. The effect of its combination has been better than that of the prevent Ayurvedic preparations such as Yogaraja Guggulu, Vatagajangusa Rasa, Amavatari Rasa and Maharasandi Kvatha. The effect of the combination of Sunthi may be attributed primarily to its effects on gastro-intestinal tract, and it being a major ingredient in all these combinations as well as sufficient dose. According to Ayurvedic Pharmaco dynamic principles the drug Sunthi possesses 'Katurasa' that is combination of Agni and Vayu Mahabhutas (Sharma Acarya Priyavrata -1976) since the
